Streszczenie
3/2020
vol. 52
List do Redakcji
Implementation of veno-venous extracorporeal membrane oxygenation in a COVID-19 convalescent
- Department of Anesthesiology, Intensive Care and Regional ECMO Center, University Hospital, Opole, Poland
- Anaesthesiology and Intensive Care Unit, District Hospital in Olawa, Poland
- Department of Anesthesiology, Intensive Care and Regional ECMO Center, Institute of Medical Sciences, University of Opole, Opole, Poland
Anestezjologia Intensywna Terapia 2020; 52, 3: 256–258
Data publikacji online: 2020/08/06
Dear Editor,
We would like to present a case of successful implementation of veno-venous extracorporeal membrane oxygenation (ECMO) in a COVID-19 convalescent. Many experts suggest that during a pandemic ECMO should be applied in strictly defined cases for COVID-19 patients, mainly because of the resource-consuming nature of extracorporeal therapy [1, 2]. Current guidelines state that ECMO is contraindicated after seven days of mechanical ventilation, including in critically ill COVID-19 patients [3]. Extracorporeal treatment in our COVID-19 convalescent was launched at the late stage of severe acute respiratory distress syndrome (ARDS), which was also affected by the onset of septic shock. We believe that this is the first case of ECMO therapy in a COVID-19 convalescent to be described in the literature. Written informed consent from the patient was obtained to present this case.
We would like to present a case of successful implementation of veno-venous extracorporeal membrane oxygenation (ECMO) in a COVID-19 convalescent. Many experts suggest that during a pandemic ECMO should be applied in strictly defined cases for COVID-19 patients, mainly because of the resource-consuming nature of extracorporeal therapy [1, 2]. Current guidelines state that ECMO is contraindicated after seven days of mechanical ventilation, including in critically ill COVID-19 patients [3]. Extracorporeal treatment in our COVID-19 convalescent was launched at the late stage of severe acute respiratory distress syndrome (ARDS), which was also affected by the onset of septic shock. We believe that this is the first case of ECMO therapy in a COVID-19 convalescent to be described in the literature. Written informed consent from the patient was obtained to present this case.